Effects of sodium-glucose cotransporter-2 inhibitors on inflammatory skin diseases in patients with type 2 diabetes

Kevin Sheng-Kai Ma; Serena Yun-Chen Tsai; Allison Holt; Steven T Chen

doi:10.1016/j.jaad.2024.04.079

Effects of sodium-glucose cotransporter-2 inhibitors on inflammatory skin diseases in patients with type 2 diabetes

J Am Acad Dermatol. 2024 Nov;91(5):934-936. doi: 10.1016/j.jaad.2024.04.079. Epub 2024 Jun 10.

Authors

Kevin Sheng-Kai Ma¹, Serena Yun-Chen Tsai², Allison Holt³, Steven T Chen⁴

Affiliations

¹ Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: kevinskma1@gmail.com.
² Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
³ Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
⁴ Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: stchen@mgb.org.

PMID: 38866183
DOI: 10.1016/j.jaad.2024.04.079

No abstract available

Keywords: acne; alopecia areata; diabetes mellitus; lichen planus; psoriasis; seborrheic dermatitis; sodium-glucose cotransporter-2 inhibitors; vitiligo.